Chief Product Officer · Beta Bionics, Inc. · Common Stock
Side
SELL
Value
$66K
Shares
2,200
Price
$30.1
Executed
Jan 6, 2026
Disclosed
Jan 7, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Jan 6 executedJan 7, 2026 disclosed
BBNX · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+4 / 15
3 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Mensinger Mike filed this Form 4 reporting a open-market sale of BBNX on Jan 6, 2026. It became public on Jan 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Product Officer
Mensinger Mikecik:0002048500
Issuer
Beta Bionics, Inc.cik:0001674632
Revision history · 0
No field has changed since this record was first ingested.
